Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects

Journal of Cell Biology

Volumn 164, Issue 4, 2004, Pages 613-623

  Kenner, Lukas ^a   Hoebertz, Astrid ^a   Beil, Timo ^b   Keon, Niamh ^c   Karreth, Florian ^a   Eferl, Robert ^a   Scheuch, Harald ^a   Szremska, Agnieszka ^a   Amling, Michael ^b   Schorpp Kistner, Marina ^c   Angel, Peter ^c   Wagner, Erwin F ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b University of Medical School Hamburg Eppendorf   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AP 1; Conditional gene targeting; Osteoblasts; Osteopenia; Osteopetrosis

Indexed keywords

CRE RECOMBINASE; CYCLIN A; CYCLIN D1; CYCLIN E; OSTEOCALCIN; PROTEIN P16; SIALOPROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RUNX2;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEATH; GENE TARGETING; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; MOUSE; NEWBORN; NONHUMAN; ONCOGENE C JUN; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DISEASES, METABOLIC; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELLS, CULTURED; FEMALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-JUN; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 10744228707     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200308155     Document Type: Article

References (42)

1. Amling, M., M. Priemel, T. Holzmann, K. Chapin, J.M. Rueger, R. Baron, and M.B. Demay. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis, formal histomorphometric and biomechanical analyses. Endocrinology. 140:4982-4987.
2. Amling, M., L. Neff, M. Priemel, A.F. Schilling, J.M. Rueger, and R. Baron. 2000. Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. Bone. 27:603-610.
3. Andrecht, S., A. Kolbus, B. Hartenstein, P. Angel, and M. Schorpp-Kistner. 2002. Cell cycle promoting activity of JunB through cyclin A activation. J. Biol. Chem. 277:35961-35968.
4. Aslam, F., L. McCabe, B. Frenkel, A.J. van Wijnen, G.S. Stein, J.B. Lian, and J.L. Stein. 1999. AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation. Endocrinology. 140:63-70.
5. Bakiri, L., D. Lallemand, E. Bossy-Wetzel, and M. Yaniv. 2000. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 19:2056-2068.
6. Behrens, A., J. Haigh, F. Mechta-Grigoriou, A. Nagy, M. Yaniv, and E.F. Wagner. 2003. Impaired intervertebral disc formation in the absence of Jun. Development. 130:103-109.
7. Chiu, R., P. Angel, and M. Karin. 1989. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell. 59:979-986.
8. Clausen, B.E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Forster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265-277.
9. Corrall, D.A., M. Amling, M. Priemel, E. Loyer, S. Fuchs, P. Ducy, R. Baron, and G. Karsenty. 1998. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc. Natl. Acad. Sci. USA. 95:13835-13840.
10. David, J.P., M. Rincon, L. Neff, W.C. Horne, and R. Baron. 2001. Carbonic anhydrase 11 is an AP-1 target gene in osteoclasts. J. Cell. Physiol. 188:89-97.
11. David, J.P., K. Sabapathy, O. Hoffmann, M.H. Idarraga, and E.F. Wagner. 2002. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 115:4317-4325.
12. Ducy, P., R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 89:747-754.
13. Ducy, P., M. Starbuck, M. Priemel, J. Shen, G. Pinero, V. Geoffroy, M. Amling, and G. Karsenty. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1025-1036.
14. Eferl, R., and E.F. Wagner. 2003. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer. 3:859-868.
15. Eferl R., M. Sibilia, F. Hilberg, A. Fuchsbichler, I. Kufferath, B. Guertl, R. Zenz, E.F. Wagner, and K. Zatloukal. 1999. Functions of c-Jun in liver and heart development. J. Cell Biol. 145:1049-1061.
16. 1 in osteoclast differentiation and survival. J. Cell Sci. 113:2445-2453.
17. Grigoriadis, A.E., K. Schellander, Z.Q. Wang, and E.F. Wagner. 1993. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122:685-701.
18. Grigoriadis, A.E., Z.Q. Wang, M.G. Cecchini, W. Hofstetter, R. Felix, H.A. Fleisch, and E.F. Wagner. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 266:443-448.
19. Hess, J., B. Hartenstein, S. Teurich, D. Schmidt, M. Schorpp-Kistner, and P. Angel. 2003. Defective endochondral ossification in mice with strongly compromised expression of JunB. J Cell Sci. 15:4587-4596.
20. Jochum, W., J.P. David, C. Elliott, A. Wutz, H. Plenk, Jr., K. Matsuo, and E.F. Wagner. 2000. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6:980-984.
21. Jochum, W., E. Passegue, and E.F. Wagner. 2001. AP-1 in mouse development and tumorigenesis. Oncogene. 20:2401-2412.
22. Karsenty, G., and E.F. Wagner. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2:389-406.
23. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguch, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:755-764.
24. Liu, W., S. Toyosawa, T. Furuichi, N. Kanatani, C. Yoshida, Y. Liu, M. Himeno, S. Narai, A. Yamaguchi, and T. Komori. 2001. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155:157-166.
25. Malaval, L., F. Liu, P. Roche, and J.E. Aubin. 1999. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J. Cell. Biochem. 74:616-627.
26. Matsuo, K., J.M. Owens, M. Tonko, C. Elliott, T.J. Chambers, and E.F. Wagner. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24:184-187.
27. McCabe, L.R., M. Kockx, J. Lian, J. Stein, and G. Stein. 1995. Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp. Cell Res. 218:255-262.
28. Murtaugh, L.C., J.H. Chyung, and A.B. Lassar. 1999. Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling. Genes Dev. 13:225-237.
29. Parfitt, A.M., M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, and R.R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610.
30. Passegue, E., and E.F. Wagner. 2000. JunB suppresses cell proliferation by transcriptional activation of p16 (INK4a) expression. EMBO J. 19:2969-2979.
31. Passegue, E., W. Jochum, M. Schorpp-Kistner, U. Mohle-Steinlein, and E.F. Wagner. 2001. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell. 104:21-32.
32. Passegue, E., W. Jochum, A. Behrens, R. Ricci, and E.F. Wagner. 2002. JunB can substitute for Jun in mouse development and cell proliferation. Nat. Genet. 30:158-166.
33. Sabatakos, G., N.A. Sims, J. Chen, K. Aoki, M.B. Kelz, M. Amling, Y. Bouali, K. Mukhopadhyay, K. Ford, E.J. Nestler, and R. Baron. 2000. Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6:985-990.
34. Schorpp, M., R. Jager, K. Schellander, J. Schenkel, E.F. Wagner, H. Weiher, and P. Angel. 1996. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 24:1787-1788.
35. Schorpp-Kistner, M., Z.Q. Wang, P. Angel, and E.F. Wagner. 1999. JunB is essential for mammalian placentation. EMBO J. 18:934-948.
36. Shaulian E., and M. Karin. 2002 AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-E136.
37. Simon, C., M. Simon, G. Vucelic, M.J. Hicks, P.K. Plinkert, A. Koitschev, and H.P. Zenner. 2001. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res. 271:344-355.
38. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3:889-901.
39. Tallquist, M.D., and P. Soriano. 2000. Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis. 26:113-115.
40. Thepot D., J.B. Weitzman, J. Barra, D. Segretain, M.G. Stinnakre, C. Babinet, and M. Yaniv. 2000. Targeted disruption of the murine junD gene results in multiple defects in male reproductive function. Development 127:143-153.
41. Wisdom, R., R.S. Johnson, and C. Moore. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18:188-197.
42. Yamauchi, M., Y. Ogata, R.H. Kim, J.J. Li, L.P. Freedman, and J. Sodek. 1996. AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within a glucocorticoid response unit in the gene promoter. Matrix Biol. 15:119-130.